{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:22:12Z","timestamp":1790634132697,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T00:00:00Z","timestamp":1603756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Lumos Pharma","award":["LUM-001"],"award-info":[{"award-number":["LUM-001"]}]},{"name":"Italian Ministry of Health","award":["GR-2017-02364378"],"award-info":[{"award-number":["GR-2017-02364378"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Creatine Transporter Deficiency (CTD) is an inborn error of metabolism presenting with intellectual disability, behavioral disturbances and epilepsy. There is currently no cure for this disorder. Here, we employed novel biomarkers for monitoring brain function, together with well-established behavioral readouts for CTD mice, to longitudinally study the therapeutic efficacy of cyclocreatine (cCr) at the preclinical level. Our results show that cCr treatment is able to partially correct hemodynamic responses and EEG abnormalities, improve cognitive deficits, revert autistic-like behaviors and protect against seizures. This study provides encouraging data to support the potential therapeutic benefit of cyclocreatine or other chemically modified lipophilic analogs of Cr.<\/jats:p>","DOI":"10.1038\/s41598-020-75436-4","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:03:40Z","timestamp":1603796620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency"],"prefix":"10.1038","volume":"10","author":[{"given":"Francesco","family":"Cacciante","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Gennaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Sagona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Lupori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cerri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Putignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Ha T.","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"McKew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Alessandr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Pizzorusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Baroncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,27]]},"reference":[{"key":"75436_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s10545-014-9713-8","volume":"37","author":"JM van de Kamp","year":"2014","unstructured":"van de Kamp, J. M., Mancini, G. M. & Salomons, G. S. X-linked creatine transporter deficiency: clinical aspects and pathophysiology. J. Inherit. Metab. Dis. 37, 715\u2013733 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"75436_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/jmedgenet-2013-101658","volume":"50","author":"JM van de Kamp","year":"2013","unstructured":"van de Kamp, J. M. et al. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency. J. Med. Genet. 50, 463\u2013472 (2013).","journal-title":"J. Med. Genet."},{"key":"75436_CR3","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/13554790802060821","volume":"14","author":"A Chilosi","year":"2008","unstructured":"Chilosi, A. et al. Treatment with l-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase 14, 151\u2013161 (2008).","journal-title":"Neurocase"},{"key":"75436_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ymgme.2010.08.016","volume":"101","author":"S Mercimek-Mahmutoglu","year":"2010","unstructured":"Mercimek-Mahmutoglu, S. et al. Treatment of intractable epilepsy in a female with SLC6A8 deficiency. Mol. Genet. Metab. 101, 409\u2013412 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"75436_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10545-011-9358-9","volume":"35","author":"V Valayannopoulos","year":"2012","unstructured":"Valayannopoulos, V. et al. Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J. Inherit. Metab. Dis. 35, 151\u2013157 (2012).","journal-title":"J. Inherit. Metab. Dis."},{"key":"75436_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2014.05.011","volume":"112","author":"M Dunbar","year":"2014","unstructured":"Dunbar, M., Jaggumantri, S., Sargent, M., Stockler-Ipsiroglu, S. & van Karnebeek, C. D. M. Treatment of X-linked creatine transporter (SLC6A8) deficiency: systematic review of the literature and three new cases. Mol. Genet. Metab. 112, 259\u2013274 (2014).","journal-title":"Mol. Genet. Metab."},{"key":"75436_CR7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pediatrneurol.2015.05.006","volume":"53","author":"S Jaggumantri","year":"2015","unstructured":"Jaggumantri, S. et al. Treatment of creatine transporter (SLC6A8) deficiency with oral S-adenosyl methionine as adjunct to L-arginine, glycine, and creatine supplements. Pediatr. Neurol. 53, 360-363.e2 (2015).","journal-title":"Pediatr. Neurol."},{"key":"75436_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.biochi.2015.10.022","volume":"119","author":"M Joncquel-Chevalier Curt","year":"2015","unstructured":"Joncquel-Chevalier Curt, M. et al. Creatine biosynthesis and transport in health and disease. Biochimie 119, 146\u2013165 (2015).","journal-title":"Biochimie"},{"key":"75436_CR9","doi-asserted-by":"publisher","first-page":"e16187","DOI":"10.1371\/journal.pone.0016187","volume":"6","author":"MR Skelton","year":"2011","unstructured":"Skelton, M. R. et al. Creatine transporter (CrT; Slc6a8) knockout mice as a model of human CrT deficiency. PLoS ONE 6, e16187 (2011).","journal-title":"PLoS ONE"},{"key":"75436_CR10","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1172\/JCI59373","volume":"122","author":"Y Kurosawa","year":"2012","unstructured":"Kurosawa, Y. et al. Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency. J. Clin. Invest. 122, 2837\u20132846 (2012).","journal-title":"J. Clin. Invest."},{"key":"75436_CR11","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1093\/hmg\/ddw252","volume":"25","author":"L Baroncelli","year":"2016","unstructured":"Baroncelli, L. et al. A mouse model for creatine transporter deficiency reveals early onset cognitive impairment and neuropathology associated with brain aging. Hum. Mol. Genet. 25, 4186\u20134200 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"75436_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3389\/fphys.2018.00773","volume":"9","author":"M Stockebrand","year":"2018","unstructured":"Stockebrand, M. et al. A mouse model of creatine transporter deficiency reveals impaired motor function and muscle energy metabolism. Front. Physiol. 9, 773 (2018).","journal-title":"Front. Physiol."},{"key":"75436_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/gbb.12461","author":"KC Udobi","year":"2018","unstructured":"Udobi, K. C. et al. Cognitive deficits and increases in creatine precursors in a brain-specific knockout of the creatine transporter gene Slc6a8. Genes Brain Behav. https:\/\/doi.org\/10.1111\/gbb.12461 (2018).","journal-title":"Genes Brain Behav."},{"key":"75436_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41598-018-37303-1","volume":"9","author":"A Molinaro","year":"2019","unstructured":"Molinaro, A. et al. A nervous system-specific model of creatine transporter deficiency recapitulates the cognitive endophenotype of the disease: a longitudinal study. Sci. Rep. 9, 62 (2019).","journal-title":"Sci. Rep."},{"key":"75436_CR15","doi-asserted-by":"publisher","unstructured":"Mazziotti, R., Cacciante, F., Sagona, G., Lupori, L., Gennaro, M., Putignano, E., Alessandr\u00ec, M. G., Ferrari, A., Battini, R., Cioni, G., Pizzorusso, T., Baroncelli, L. Novel translational phenotypes and biomarkers for creatine transporter deficiency. Brain Commun. 2(2), fcaa089. https:\/\/doi.org\/10.1093\/braincomms\/fcaa089 (2020).","DOI":"10.1093\/braincomms\/fcaa089"},{"key":"75436_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2217\/nnm.13.205","volume":"10","author":"A Trotier-Faurion","year":"2015","unstructured":"Trotier-Faurion, A. et al. Dodecyl creatine ester and lipid nanocapsule: a double strategy for the treatment of creatine transporter deficiency. Nanomedicine 10, 185\u2013191 (2015).","journal-title":"Nanomedicine"},{"key":"75436_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neuroscience.2016.02.038","volume":"340","author":"E Adriano","year":"2017","unstructured":"Adriano, E. et al. Creatine salts provide neuroprotection even after partial impairment of the creatine transporter. Neuroscience 340, 299\u2013307 (2017).","journal-title":"Neuroscience"},{"key":"75436_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.neulet.2017.12.020","volume":"665","author":"E Adriano","year":"2018","unstructured":"Adriano, E. et al. Di-acetyl creatine ethyl ester, a new creatine derivative for the possible treatment of creatine transporter deficiency. Neurosci. Lett. 665, 217\u2013223 (2018).","journal-title":"Neurosci. Lett."},{"key":"75436_CR19","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2217\/nnm-2019-0059","volume":"14","author":"G Ullio-Gamboa","year":"2019","unstructured":"Ullio-Gamboa, G. et al. Dodecyl creatine ester-loaded nanoemulsion as a promising therapy for creatine transporter deficiency. Nanomedicine 14, 1579\u20131593 (2019).","journal-title":"Nanomedicine"},{"key":"75436_CR20","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1016\/S0021-9258(19)45084-9","volume":"247","author":"AC McLaughlin","year":"1972","unstructured":"McLaughlin, A. C., Cohn, M. & Kenyon, G. L. Specificity of creatine kinase for guanidino substrates. Kinetic and proton nuclear magnetic relaxation rate studies. J. Biol. Chem. 247, 4382\u20134388 (1972).","journal-title":"J. Biol. Chem."},{"key":"75436_CR21","doi-asserted-by":"publisher","first-page":"e00525","DOI":"10.1002\/prp2.525","volume":"7","author":"K Gorshkov","year":"2019","unstructured":"Gorshkov, K. et al. Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts. Pharmacol. Res. Perspect. 7, e00525 (2019).","journal-title":"Pharmacol. Res. Perspect."},{"key":"75436_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature09965","volume":"472","author":"J Pe\u00e7a","year":"2011","unstructured":"Pe\u00e7a, J. et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472, 437\u2013442 (2011).","journal-title":"Nature"},{"key":"75436_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2011.08.040","volume":"147","author":"O Pe\u00f1agarikano","year":"2011","unstructured":"Pe\u00f1agarikano, O. et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147, 235\u2013246 (2011).","journal-title":"Cell"},{"key":"75436_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1126\/science.1232380","volume":"340","author":"E Burgui\u00e8re","year":"2013","unstructured":"Burgui\u00e8re, E., Monteiro, P., Feng, G. & Graybiel, A. M. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 340, 1243\u20131246 (2013).","journal-title":"Science"},{"key":"75436_CR25","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nature13248","volume":"511","author":"T Karayannis","year":"2014","unstructured":"Karayannis, T. et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature 511, 236\u2013240 (2014).","journal-title":"Nature"},{"key":"75436_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.cell.2014.04.045","volume":"158","author":"PE Rothwell","year":"2014","unstructured":"Rothwell, P. E. et al. Autism-associated neuroligin-3 mutations commonly impair striatal circuits to boost repetitive behaviors. Cell 158, 198\u2013212 (2014).","journal-title":"Cell"},{"key":"75436_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnins.2016.00027","volume":"10","author":"MV Fuccillo","year":"2016","unstructured":"Fuccillo, M. V. Striatal circuits as a common node for autism pathophysiology. Front. Neurosci. 10, 27 (2016).","journal-title":"Front. Neurosci."},{"key":"75436_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrn.2015.8","volume":"17","author":"AV Kalueff","year":"2016","unstructured":"Kalueff, A. V. et al. Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat. Rev. Neurosci. 17, 45\u201359 (2016).","journal-title":"Nat. Rev. Neurosci."},{"key":"75436_CR29","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1038\/s41598-018-19844-7","volume":"8","author":"T Hisaoka","year":"2018","unstructured":"Hisaoka, T., Komori, T., Kitamura, T. & Morikawa, Y. Abnormal behaviours relevant to neurodevelopmental disorders in Kirrel3-knockout mice. Sci. Rep. 8, 1408 (2018).","journal-title":"Sci. Rep."},{"key":"75436_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta, S. & Sengupta, P. Men and mice: relating their ages. Life Sci. 152, 244\u2013248 (2016).","journal-title":"Life Sci."},{"key":"75436_CR31","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1055\/s-0034-1386772","volume":"34","author":"S Stockler-Ipsiroglu","year":"2014","unstructured":"Stockler-Ipsiroglu, S. & van Karnebeek, C. D. M. Cerebral creatine deficiencies: a group of treatable intellectual developmental disorders. Semin. Neurol. 34, 350\u2013356 (2014).","journal-title":"Semin. Neurol."},{"key":"75436_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4020-6486-9_9","volume":"46","author":"A Schulze","year":"2007","unstructured":"Schulze, A. & Battini, R. Pre-symptomatic treatment of creatine biosynthesis defects. Subcell. Biochem. 46, 167\u2013181 (2007).","journal-title":"Subcell. Biochem."},{"key":"75436_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.neubiorev.2009.07.008","volume":"34","author":"S Lloyd-Fox","year":"2010","unstructured":"Lloyd-Fox, S., Blasi, A. & Elwell, C. E. Illuminating the developing brain: the past, present and future of functional near infrared spectroscopy. Neurosci. Biobehav. Rev. 34, 269\u2013284 (2010).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Pt 1","key":"75436_CR34","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2013.10.009","volume":"85","author":"RE Vanderwert","year":"2014","unstructured":"Vanderwert, R. E. & Nelson, C. A. The use of near-infrared spectroscopy in the study of typical and atypical development. Neuroimage 85(Pt 1), 264\u2013271 (2014).","journal-title":"Neuroimage"},{"key":"75436_CR35","doi-asserted-by":"publisher","first-page":"801","DOI":"10.5665\/sleep.5632","volume":"39","author":"BA Riedner","year":"2016","unstructured":"Riedner, B. A. et al. Regional patterns of elevated alpha and high-frequency electroencephalographic activity during nonrapid eye movement sleep in chronic insomnia: a pilot study. Sleep 39, 801\u2013812 (2016).","journal-title":"Sleep"},{"key":"75436_CR36","doi-asserted-by":"publisher","first-page":"104428","DOI":"10.1016\/j.dib.2019.104428","volume":"26","author":"M Rezaei","year":"2019","unstructured":"Rezaei, M., Khaledi Paveh, B., Maazinezhad, S. & Khazaie, H. Respiration data on sleep state misperception, psychophysiological insomnia and normal individuals from a cross sectional study. Data Brief 26, 104428 (2019).","journal-title":"Data Brief"},{"key":"75436_CR37","doi-asserted-by":"publisher","first-page":"104750","DOI":"10.1016\/j.yrtph.2020.104750","volume":"117","author":"VP Kale","year":"2020","unstructured":"Kale, V. P. et al. Evaluation of chronic toxicity of cyclocreatine, a creatine analog, in Sprague Dawley rat after oral gavage administration for up to 26 weeks. Regul. Toxicol. Pharmacol. 117, 104750 (2020).","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"75436_CR38","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1142\/S0219635213500155","volume":"12","author":"A Enrico","year":"2013","unstructured":"Enrico, A. et al. Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices. J. Integr. Neurosci. 12, 285\u2013297 (2013).","journal-title":"J. Integr. Neurosci."},{"key":"75436_CR39","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.5369.1","volume":"3","author":"L Baroncelli","year":"2014","unstructured":"Baroncelli, L. et al. A novel mouse model of creatine transporter deficiency. F1000Res 3, 228 (2014).","journal-title":"F1000Res"},{"key":"75436_CR40","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1093\/hmg\/ddx119","volume":"26","author":"R Mazziotti","year":"2017","unstructured":"Mazziotti, R. et al. Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice. Hum. Mol. Genet. 26, 2290\u20132298 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"75436_CR41","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/hmg\/ddz102","volume":"28","author":"L Lupori","year":"2019","unstructured":"Lupori, L. et al. Site-specific abnormalities in the visual system of a mouse model of CDKL5 deficiency disorder. Hum. Mol. Genet. 28, 2851\u20132861 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"75436_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine, R. J. Modification of seizure activity by electrical stimulation II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32, 281\u2013294 (1972).","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"75436_CR43","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0024-3205(01)01268-1","volume":"69","author":"OS Ipsiroglu","year":"2001","unstructured":"Ipsiroglu, O. S. et al. Changes of tissue creatine concentrations upon oral supplementation of creatine-monohydrate in various animal species. Life Sci. 69, 1805\u20131815 (2001).","journal-title":"Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75436-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75436-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T22:18:11Z","timestamp":1670365091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-75436-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["75436"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-75436-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,27]]},"assertion":[{"value":"20 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors report no competing interests, except for funding obtained to carry out the research. M. T. Do and J. C. McKew are employees of Lumos Pharma. Cyclocreatine used in this study was being developed by Lumos Pharma.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18361"}}